CLEARASIL ULTRA OVERNIGHT FACE- salicylic acid lotion 
RB Health (US) LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Clearasil ®
ULTRA ®

Drug Facts

Active Ingredient

Salicyclic acid 2%

Purpose

Acne Medication

Use

for the treatment of acne

Warnings

For external use only

When using this product

  • Avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water
  • With other topical acne medications, at the same time or immediately following use of this product, increased dryness or irritation of the skin may occur. If this occurs, only one acne medication should be used unless directed by your doctor
  • Limit use to the face and neck

Stop use and ask a doctor ifskin or eye irritation develops.

Keep out of reach of children.In case of accidental ingestion, get medical help or contact a Poison Control Center immediately.

Directions

Other information

Inactive ingredients

Water, Butylene Glycol, Octyldodecanol, Steareth-2, Cetyl Alcohol, Steareth-21, Dimethicone, Polyacrylamide Glycerin, C13-14 Isoparaffin, Phenoxyethanol, Sodium Hydroxide, Xanthan Gum, Magnesium Aluminum Silicate, Laureth-7, Fragrance, Lavandula Stoechas Extract, Helichrysum Italicum Extract, Cistus Monspeliensis Extract, Methylparaben, Butylparaben, Ethylparaben, Isobutylparaben, Propylparaben, Titanium Dioxide

Questions?

Call 1-866-25-CLEAR (1-866-252-5327).

You may also report side effects to this phone number.

Distributed by: Reckitt Benckiser LLC
Parsippany, NJ 07054-0224

PRINCIPAL DISPLAY PANEL - 38.4 mL Tube Carton

Clearasil®

ULTRA®

Overnight
Face Lotion

Salicylic Acid 2% Acne Medication

Helps
visibly reduce
pimple size
and redness
overnight

1.3 FL. OZ. (38.4 mL)

PRINCIPAL DISPLAY PANEL - 38.4 mL Tube Carton
CLEARASIL ULTRA  OVERNIGHT FACE
salicylic acid lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63824-339
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
OCTYLDODECANOL (UNII: 461N1O614Y)  
STEARETH-2 (UNII: V56DFE46J5)  
CETYL ALCOHOL (UNII: 936JST6JCN)  
STEARETH-21 (UNII: 53J3F32P58)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
C13-14 ISOPARAFFIN (UNII: E4F12ROE70)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
XANTHAN GUM (UNII: TTV12P4NEE)  
MAGNESIUM ALUMINUM SILICATE (UNII: 6M3P64V0NC)  
LAURETH-7 (UNII: Z95S6G8201)  
LAVANDULA STOECHAS FLOWERING TOP (UNII: 70759G2U6A)  
HELICHRYSUM ITALICUM FLOWER OIL (UNII: O97ZV7726K)  
METHYLPARABEN (UNII: A2I8C7HI9T)  
BUTYLPARABEN (UNII: 3QPI1U3FV8)  
ETHYLPARABEN (UNII: 14255EXE39)  
ISOBUTYLPARABEN (UNII: 0QQJ25X58G)  
PROPYLPARABEN (UNII: Z8IX2SC1OH)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63824-339-0138.4 mL in 1 TUBE; Type 0: Not a Combination Product08/18/201109/01/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D08/18/201109/01/2024
Labeler - RB Health (US) LLC (081049410)

Revised: 7/2023
Document Id: 00de7ec5-1bbc-d1b6-e063-6394a90a555a
Set id: d4b568c5-05b6-41fe-831a-d91313694d6b
Version: 3
Effective Time: 20230719
 
RB Health (US) LLC